The findings of this study introduce novel insights into the clinical utility of combining PedPne with inflammatory biomarkers such as dNLR and IL-6 for diagnosing and managing pneumonia in pediatric patients post-SARS-CoV-2 infection. The gene discussed is IL6; the disease is susceptibility to pneumonia measurement.